Paul Hall's Contact Details

Paul Hall's Company Details

Bioscience Vaccines, Inc.

West Lafayette, Indiana, United States • 36 Employees
Biotechnology

Bioscience Vaccines, Inc. (BVI) is a life science company focused on improving the efficacy of vaccines. We will accelerate advancements in the development of vaccines used in the prevention and treatment of various infectious diseases with our proprietary Matrix Immune Modulator™ (MIM). Additionally, the technology can be used for the development of biological warfare vaccines. Bioscience Vaccines, Inc.'s novel technology is derived from an abundant, naturally occurring biomaterial referred to as an extracellular matrix. MIM has the potential to be formulated as a companion product with vaccines already approved by the FDA as well as vaccines currently in the development pipeline. MIM is currently available in 3 different formulations (MIM90, MIM150, and MIM250). The base technology has been used in ~2 million patients worldwide for medical device applications with >10 years of safety data. BVI has 22 domestic and international patents pending for vaccine development targeted for human and animals for the prevention and treatment of infectious diseases and cancer based on research performed at the University of Notre Dame.